Related Experiment Video

Updated: Jun 4, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema

Harikrishna Makani1, Sripal Bangalore, Jorge Romero

  • 1St Luke's Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, NY 10019, USA.

The American Journal of Medicine
|February 8, 2011
PubMed

Insights

Combining calcium channel blockers with renin-angiotensin system blockers significantly reduces peripheral edema in hypertension patients. Angiotensin-converting enzyme inhibitors appear more effective than ARBs for this side effect.

Area of Science:

  • Cardiology
  • Pharmacology
  • Hypertension Management

Background:

  • Peripheral edema is a frequent adverse effect of calcium channel blocker (CCB) therapy.
  • Renin-angiotensin system (RAS) blockers, including ACE inhibitors and ARBs, can mitigate CCB-induced peripheral edema.

Purpose of the Study:

  • To evaluate the efficacy of combining CCBs with RAS blockers in reducing peripheral edema.
  • To compare the effectiveness of ACE inhibitors versus ARBs in preventing CCB-associated peripheral edema.

Main Methods:

  • A systematic review and meta-analysis of prospective randomized controlled trials (RCTs) from 1980 to present.
  • Included trials compared CCB monotherapy with CCB/RAS blocker combination in hypertensive patients with >100 participants.
  • Data on peripheral edema incidence and withdrawal rates were analyzed.

Main Results:

  • Combination therapy significantly reduced peripheral edema incidence by 38% (RR 0.62) and withdrawal rates by 62% (RR 0.38) compared to CCB monotherapy.
  • ACE inhibitors demonstrated greater efficacy than ARBs in reducing peripheral edema (indirect comparison).
  • Analysis included 25 RCTs with 17,206 patients over a mean duration of 9.2 weeks.

Conclusions:

  • CCB/RAS blocker combination therapy is effective in reducing peripheral edema in hypertensive patients.
  • ACE inhibitors may be superior to ARBs in mitigating CCB-associated peripheral edema, warranting further head-to-head studies.
Abstract

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...